BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38584831)

  • 1. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis.
    Shen LP; Jiang HT
    Open Med (Wars); 2024; 19(1):20240929. PubMed ID: 38584831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer genetic analysis of disulfidptosis-related gene set.
    Liu H; Tang T
    Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
    Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
    Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
    Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
    Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma.
    Qi C; Ma J; Sun J; Wu X; Ding J
    Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Sun XY; Xiao M; Fu M; Gao Q; Li RF; Wang J; Li SL; Ge XY
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of disulfidptosis-related genes and subgroups in Alzheimer's disease.
    Ma S; Wang D; Xie D
    Front Aging Neurosci; 2023; 15():1236490. PubMed ID: 37600517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study.
    Chen X; Liang Q; Zhou Y
    Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma.
    Mengzhen Z; Xinwei H; Zeheng T; Nan L; Yang Y; Huirong Y; Kaisi F; Xiaoting D; Liucheng Y; Kai W
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):109. PubMed ID: 38427078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
    Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
    Yan J; Fang Z; Shi M; Tu C; Zhang S; Jiang C; Li Q; Shao Y
    J Cancer; 2024; 15(4):1053-1066. PubMed ID: 38230212
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
    Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K
    Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfidptosis and its Role in Peripheral Blood Immune Cells after a Stroke: A New Frontier in Stroke Pathogenesis.
    Liu SP; Liu C; Xu B; Zhou H; Zhao H
    Curr Neurovasc Res; 2024 Jan; ():. PubMed ID: 38299279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfidptosis: Six Riddles Necessitating Solutions.
    Wang X; Zheng C; Yao H; Guo Y; Wang Y; He G; Fu S; Deng X
    Int J Biol Sci; 2024; 20(3):1042-1044. PubMed ID: 38322120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.
    Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G
    Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669
    [No Abstract]   [Full Text] [Related]  

  • 16. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
    Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
    Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature.
    Tang C; Fan Y; Zhu S
    BMC Urol; 2024 Mar; 24(1):69. PubMed ID: 38532369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma.
    Xin S; Li R; Su J; Cao Q; Wang H; Wei Z; Li G; Qin W; Zhang Z; Wang C; Zhang C; Zhang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13925-13942. PubMed ID: 37541976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling diagnostic clusters and immune landscapes of disulfidptosis patterns in gastric cancer through bioinformatic assay.
    Zhang P; Chen Z; Lin X; Yu S; Yu X; Chen Z
    Aging (Albany NY); 2023 Dec; 15(24):15434-15450. PubMed ID: 38154092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.